Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 315

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Outcomes After Current Transcatheter Tricuspid Valve Intervention

Open access
Taramasso, Maurizio, Alessandrini, Hannes, Latib, Azeem, Asami, Masahiko, Attinger-Toller, Adrian, Biasco, Luigi, Braun, Daniel, Brochet, Eric, Connelly, Kim A., Denti, Paolo, Deuschl, Florian, Englmeier, Andrea, Fam, Neil, Frerker, Christian, Hausleiter, Jörg, Himbert, Dominique, Ho, Edwin C., Juliard, Jean-Michel, Kaple, Ryan, Kreidel, Felix, Kuck, Karl-Heinz, Ancona, Marco, Lauten, Alexander, Lurz, Philipp, Mehr, Michael, Nazif, Tamin, Nickening, Georg, Pedrazzini, Giovanni, Pozzoli, Alberto, Praz, Fabien, Puri, Rishi, Rodés-Cabau, Josep, Schäfer, Ulrich, Schofer, Joachim, Sievert, Horst, Sievert, Kolja, Tang, Gilbert H.L., Tanner, Felix C., Vahanian, Alec, Webb, John G., Windecker, Stephan, Yzeiray, Ermela, Zuber, Michel, Maisano, Francesco, Leon, Martin B., Hahn, Rebecca T. · 2019 · JACC: Cardiovascular Interventions

Abstract

OBJECTIVES A large, prospective international registry was developed to evaluate the initial clinical applications of transcatheter tricuspid valve intervention (TTVI) with different devices. BACKGROUND TTVI for native tricuspid valve dysfunction has been emerging during the last few years as an alternative therapeutic option to serve a large high-risk population of patients with severe symptomatic tricuspid regurgitation (TR). METHODS The TriValve Registry included 312 high-risk patients with severe TR (76.4 ± 8.5 years of age; 57% female; EuroSCORE II 9 ± 8%) at 18 centers. Interventions included repair at the level of the leaflets (MitraClip, Abbott Vascular, Santa Clara, California; PASCAL Edwards Lifesciences, Irvine, California), annulus (Cardioband, Edwards Lifesciences; TriCinch, 4tech, Galway, Ireland; Trialign, Mitraling, Tewksbury, Massachusetts), or coaptation (FORMA, Edwards Lifesciences) and replacement (Caval Implants, NaviGate, NaviGate Cardiac Structures, Lake Forest, California). Clinical outcomes were prospectively determined during mid-term follow-up. RESULTS A total of 108 patients (34.6%) had prior left heart valve intervention (84 surgical and 24 transcatheter, respectively). TR etiology was functional in 93%, and mean annular diameter was 46.9 ± 9 mm. In 75% of patients the regurgitant jet was central (vena contracta 1.1 ± 0.5; effective regurgitant orifice area 0.78 ± 0.6 cm2). Pre-procedural systolic pulmonary artery pressure was 41 ± 14.8 mm Hg. Implanted devices included: MitraClip in 210 cases, Trialign in 18 cases, TriCinch first generation in 14 cases, caval valve implantation in 30 cases, FORMA in 24 cases, Cardioband in 13 cases, NaviGate in 6 cases, and PASCAL in 1. In 64% of the cases, TTVI was performed as a stand-alone procedure. Procedural success (defined as the device successfully implanted and residual TR ≤2+) was 72.8%. Greater coaptation depth (odds ratio: 24.1; p = 0.002) was an independent predictor of reduced device success. Thirty-day mortality was 3.6% and was significantly lower among patients with procedural success (1.9% vs. 6.9%; p = 0.04); Actuarial survival at 1.5 years was 82.8 ± 4% and was significantly higher among patients who had procedural success achieved. CONCLUSIONS TTVI is feasible with different technologies, has a reasonable overall procedural success rate, and is associated with low mortality and significant clinical improvement. Mid-term survival is favorable in this high-risk population. Greater coaptation depth is associated with reduced procedural success, which is an independent predictor of mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcin.2018.10.022

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 315

Metadata

Authors
Taramasso, M., Alessandrini, H., Latib, A., Asami, M., Attinger-Toller, A., Biasco, L., Braun, D., Brochet, E., Connelly, K. A., Denti, P., Deuschl, F., Englmeier, A., Fam, N., Frerker, C., Hausleiter, J., Himbert, D., Ho, E. C., Juliard, J.-M., Kaple, R., Kreidel, F., Kuck, K.-H., Ancona, M., Lauten, A., Lurz, P., Mehr, M., Nazif, T., Nickening, G., Pedrazzini, G., Pozzoli, A., Praz, F., Puri, R., Rodés-Cabau, J., Schäfer, U., Schofer, J., Sievert, H., Sievert, K., Tang, G. H. L., Tanner, F. C., Vahanian, A., Webb, J. G., Windecker, S., Yzeiray, E., Zuber, M., Maisano, F., Leon, M. B., & Hahn, R. T.
Venue
JACC: Cardiovascular Interventions
Publisher
Elsevier BV
Published
2019-01
Volume
12
Issue
2
Pages
155-165
ISSN
  • 1876-7605 (ISSN-L)
  • 1936-8798
OpenAlex
W2906516989
Cited by
315
References
20
FWCI
27.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes After Current Transcatheter Tricuspid Valve Intervention. https://app.cochat.ai/papers/10.1016/j.jcin.2018.10.022
The paper
Taramasso, M., Alessandrini, H., Latib, A., Asami, M., Attinger-Toller, A., Biasco, L., Braun, D., Brochet, E., Connelly, K. A., Denti, P., Deuschl, F., Englmeier, A., Fam, N., Frerker, C., Hausleiter, J., Himbert, D., Ho, E. C., Juliard, J.-M., Kaple, R., . . . Hahn, R. T. (2019). Outcomes After Current Transcatheter Tricuspid Valve Intervention. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2018.10.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.